Search

everythinglearnresearchcommunity

for

Search:↓

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

Heparin treatment may help manage pemphigus vulgaris in dogs.

The document concludes that more research is needed to find effective treatments for Lichen planopilaris and Frontal fibrosing alopecia.

A Doberman Pinscher had a rare form of autoimmune disease causing hair loss and other severe symptoms.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

The 2012 criteria are better for diagnosing atypical lupus cases.

Alopecia areata patients have a higher risk of subclinical atherosclerosis, and carotid ultrasound can help assess their cardiovascular risk.

Targeting thyroid hormone receptor α in liver cells may help treat liver fibrosis.

Different types of atopic dermatitis were linked to specific genetic and immune changes, suggesting that severe cases might need stronger immune-targeting treatments.

Hormonal therapies can improve skin issues by adjusting hormone levels, with future advancements promising better results.

Hyaluronic acid injections can improve mouth opening and quality of life in scleroderma patients.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

New treatments like biologics and JAK inhibitors show promise for severe scalp inflammation when traditional methods fail.

Pregnancy can cause skin changes, some harmless and others risky, needing careful management.

Tinea capitis in older adults is often misdiagnosed but can be effectively treated with antifungal therapy.

Cyclophosphamide is preferred for severe cases in pediatric rheumatology and nephrology despite its side effects.

Early genetic testing and JAK inhibitors can help treat systemic inflammation in SAVI patients.

Experts recommend personalized treatment plans for best outcomes in managing Alopecia Areata.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

A personalized treatment combining traditional and new therapies may improve hair loss outcomes in alopecia areata.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Primary cicatricial alopecia, a rare disorder causing permanent hair loss, is hard to diagnose and treat, with treatments like anti-inflammatory drugs and steroids offering varied results and no guaranteed cure. Psychological support for patients is important, and future research should aim to identify causes of the condition.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Some patients developed hair loss after islet cell transplant possibly due to their immune-suppressing medications.

A 70-year-old woman with bronchiectasis developed a rare immune disease due to a bacterial infection, requiring a difficult balance of treatments.

Removing certain hair follicle stem cells worsens skin reactions to allergens.

Pharmaceutical care in transplantation faces challenges but has promising future opportunities for better outcomes.

Adenosine receptors could be promising targets for treating inflammatory skin diseases like psoriasis.

Combining systemic and topical treatments effectively cured a dog's skin condition.